Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant Vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. Tomas Kalincik , Sifat Sharmin , Izanne Roos , Mark S. Freedman , Harold Atkins , Joachim Burman , Jennifer Massey , Ian Sutton , Barbara Withers , Richard Macdonell , Andrew Grigg , Oivind Torkildsen , Lars Bo , Anne Kristine Lehmann , Eva Kubala Havrdova , Eva Krasulova , Marek Trneny , Tomas Kozak , Anneke van der Walt , Helmut Butzkueven , Pamela McCombe , Olga Skibina , Jeannette Lechner-Scott , Barbara Willekens , Elisabetta Cartechini , Serkan Ozakbas , Raed Alroughani , Jens Kuhle , Francesco Patti , Pierre Duquette , Alessandra Lugaresi , Samia J. Khoury , Mark Slee , Recai Turkoglu , Suzanne Hodgkinson , Nevin John , Davide Maimone , Maria Jose Sa , Vincent van Pesch , Oliver Gerlach , Guy Laureys , Liesbeth Van Hijfte , Rana Karabudak , Daniele Spitaleri , Tunde Csepany , Riadh Gouider , Tamara Castillo-Trivino , Bruce Taylor , Basil Sharrack , John A. Snowden JAMA NEUROLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
